ambroxol has been researched along with Lung Diseases, Obstructive in 22 studies
Ambroxol: A metabolite of BROMHEXINE that stimulates mucociliary action and clears the air passages in the respiratory tract. It is usually administered as the hydrochloride.
Lung Diseases, Obstructive: Any disorder marked by obstruction of conducting airways of the lung. AIRWAY OBSTRUCTION may be acute, chronic, intermittent, or persistent.
| Excerpt | Relevance | Reference |
|---|---|---|
| "A comparison between the action of Ambroxol and Acetylcysteine was carried out in 28 children aged 2 to 13 (mean 7 years 3 months) affected with spastic bronchitis." | 9.06 | [A controlled study on the action of a new formulation of ambroxol in asthmatiform bronchitis in children]. ( Baldini, G; Gucci, M; Memmini, C; Tarò, D, 1989) |
| "Ambroxol was associated with a 25% reduction of the average bronchial flow resistance." | 6.64 | [Clinical results in the treatment of chronic obstructive bronchitis with ambroxol in comparison with bromhexine (author's transl)]. ( Niemeyer, K; Wiessmann, KJ, 1978) |
| "A comparison between the action of Ambroxol and Acetylcysteine was carried out in 28 children aged 2 to 13 (mean 7 years 3 months) affected with spastic bronchitis." | 5.06 | [A controlled study on the action of a new formulation of ambroxol in asthmatiform bronchitis in children]. ( Baldini, G; Gucci, M; Memmini, C; Tarò, D, 1989) |
| "The clinical activity of trans-4-[(2-amino-3,5-dibromo-benzyl)-amino]-cyclohexanol-hydrochloride (ambroxol, NA 872) as well as its influence on lung function was examined in a total of 63 patients (34 suffering from silicosis, 28 from chronic obstructive bronchitis and 1 from cryptococcosis)." | 3.66 | [Therapeutic study on ambroxol in chronic bronchopulmonary diseases (author's transl)]. ( Curti, PC; Renovanz, HD, 1978) |
| "Ambroxol does not increase ofloxacin concentrations in bronchial tissue because high concentrations are already present in the lung." | 2.68 | Evaluation of the effects of ambroxol on the ofloxacin concentrations in bronchial tissues in COPD patients with infectious exacerbation. ( Bouvet, O; Bressolle, F; Chanez, P; Fabre, D; Galtier, M; Godard, P; Michel, FB; Paganin, F, 1995) |
| "There was a significant difference in atelectasis between the 2 groups (10." | 2.67 | Prevention by ambroxol of bronchopulmonary complications after upper abdominal surgery: double-blind Italian multicenter clinical study versus placebo. ( Fegiz, G, 1991) |
| "Ambroxol was effective in only 1 of 5 tested lung areas and did not prove to enhance whole lung clearance significantly." | 2.65 | Effects of a beta adrenergic drug and a secretolytic agent on regional mucociliary clearance in patients with COLD. ( Dorow, P; Felix, R; Weiss, T, 1981) |
| "Ambroxol was associated with a 25% reduction of the average bronchial flow resistance." | 2.64 | [Clinical results in the treatment of chronic obstructive bronchitis with ambroxol in comparison with bromhexine (author's transl)]. ( Niemeyer, K; Wiessmann, KJ, 1978) |
| " The drug was given orally in a dosage of 100 mg BID for ten days." | 1.27 | Therapeutic activity of ambroxol theophyllinacetate in chronic obstructive pulmonary diseases. ( Primbs, K, 1985) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 11 (50.00) | 18.7374 |
| 1990's | 8 (36.36) | 18.2507 |
| 2000's | 3 (13.64) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sharafkhaneh, A | 1 |
| Velamuri, S | 1 |
| Badmaev, V | 1 |
| Lan, C | 1 |
| Hanania, N | 1 |
| Pozzi, E | 1 |
| Weiss, T | 4 |
| Dorow, P | 4 |
| Felix, R | 3 |
| Král, B | 1 |
| Ellás, J | 1 |
| Rozánek, P | 1 |
| Jirkal, J | 1 |
| Tilser, P | 1 |
| Puścińska, E | 1 |
| Radwan, L | 1 |
| Zieliński, J | 1 |
| Paganin, F | 1 |
| Bouvet, O | 1 |
| Chanez, P | 1 |
| Fabre, D | 1 |
| Galtier, M | 1 |
| Godard, P | 1 |
| Michel, FB | 1 |
| Bressolle, F | 1 |
| Serrano, J | 1 |
| Sanchis, J | 1 |
| Teramoto, S | 1 |
| Suzuki, M | 1 |
| Ohga, E | 1 |
| Ishii, T | 1 |
| Matsui, H | 1 |
| Matsuse, T | 1 |
| Ouchi, Y | 1 |
| Ekberg-Jansson, A | 1 |
| Larsson, S | 1 |
| Löfdahl, CG | 1 |
| Wiessmann, KJ | 1 |
| Niemeyer, K | 1 |
| Curti, PC | 1 |
| Renovanz, HD | 1 |
| Winsel, K | 1 |
| Lusuardi, M | 1 |
| Capelli, A | 1 |
| Carli, S | 1 |
| Tacconi, MT | 1 |
| Salmona, M | 1 |
| Donner, CF | 1 |
| Fegiz, G | 1 |
| Bavaro, P | 1 |
| Biscari, P | 1 |
| Baldini, G | 1 |
| Gucci, M | 1 |
| Tarò, D | 1 |
| Memmini, C | 1 |
| Lunichkina, IV | 1 |
| Solopov, VN | 1 |
| Schmutzler, H | 1 |
| Primbs, K | 1 |
5 reviews available for ambroxol and Lung Diseases, Obstructive
| Article | Year |
|---|---|
The potential role of natural agents in treatment of airway inflammation.
Topics: Ambroxol; Anti-Inflammatory Agents, Non-Steroidal; Curcumin; Cystic Fibrosis; Diet; Expectorants; Hu | 2007 |
Acebrophylline: an airway mucoregulator and anti-inflammatory agent.
Topics: Adult; Ambroxol; Child; Humans; Lung Diseases, Obstructive; Theophylline | 2007 |
[Usefulness of mucoactive drugs in respiratory diseases].
Topics: Acetylcysteine; Ambroxol; Bromhexine; Bronchiectasis; Bronchitis; Cystic Fibrosis; Deoxyribonuclease | 1998 |
[The antioxidative and inflammation inhibiting properties of ambroxol].
Topics: Ambroxol; Animals; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antioxidants; | 1992 |
Role of surfactant in chronic obstructive pulmonary disease: therapeutic implications.
Topics: Adult; Ambroxol; Bronchoalveolar Lavage Fluid; Humans; Lung Diseases, Obstructive; Middle Aged; Phos | 1992 |
11 trials available for ambroxol and Lung Diseases, Obstructive
| Article | Year |
|---|---|
Effects of a beta adrenergic drug and a secretolytic agent on regional mucociliary clearance in patients with COLD.
Topics: Albumins; Ambroxol; Bromhexine; Cilia; Clenbuterol; Clinical Trials as Topic; Double-Blind Method; E | 1981 |
Clinical study on Lasolvan in chronic obstructive pulmonary disease.
Topics: Ambroxol; Bromhexine; Clinical Trials as Topic; Female; Humans; Lung Diseases, Obstructive; Male | 1981 |
[The effect of ambroxol on mucociliary clearance (author's transl)].
Topics: Ambroxol; Bromhexine; Double-Blind Method; Female; Humans; Lung Diseases, Obstructive; Male; Metabol | 1981 |
[Effect of intravenous ambroxol hydrochloride on lung function and exercise capacity in patients with severe chronic obstructive pulmonary disease].
Topics: Aged; Ambroxol; Female; Humans; Infusions, Intravenous; Lung Diseases, Obstructive; Male; Middle Age | 1994 |
Evaluation of the effects of ambroxol on the ofloxacin concentrations in bronchial tissues in COPD patients with infectious exacerbation.
Topics: Administration, Oral; Aged; Ambroxol; Anti-Infective Agents; Biopsy; Bronchi; Bronchoscopy; Chromato | 1995 |
Effects of ambroxol on spontaneous or stimulated generation of reactive oxygen species by bronchoalveolar lavage cells harvested from patients with or without chronic obstructive pulmonary diseases.
Topics: Aged; Ambroxol; Bronchoalveolar Lavage Fluid; Cell Count; Expectorants; Female; Free Radicals; Human | 1999 |
[Clinical results in the treatment of chronic obstructive bronchitis with ambroxol in comparison with bromhexine (author's transl)].
Topics: Adult; Aged; Airway Resistance; Ambroxol; Bromhexine; Bronchitis; Chronic Disease; Clinical Trials a | 1978 |
Prevention by ambroxol of bronchopulmonary complications after upper abdominal surgery: double-blind Italian multicenter clinical study versus placebo.
Topics: Adult; Aged; Ambroxol; Double-Blind Method; Female; Forced Expiratory Volume; Humans; Lung Diseases, | 1991 |
[A controlled study on the action of a new formulation of ambroxol in asthmatiform bronchitis in children].
Topics: Acetylcysteine; Adolescent; Ambroxol; Bromhexine; Bronchitis; Child; Child, Preschool; Clinical Tria | 1989 |
[Modification of mucociliary clearance by a combination of theophylline with ambroxol and of ambroxol in monotherapy].
Topics: Adult; Aerosols; Ambroxol; Bromhexine; Clinical Trials as Topic; Double-Blind Method; Humans; Lung D | 1988 |
[Effect of a secretolytic and a combination of pinene, limonene and cineole on mucociliary clearance in patients with chronic obstructive pulmonary disease].
Topics: Adult; Aged; Ambroxol; Bromhexine; Drug Combinations; Drug Therapy, Combination; Female; Humans; Lun | 1987 |
6 other studies available for ambroxol and Lung Diseases, Obstructive
| Article | Year |
|---|---|
[COPD--a neglected disease entity].
Topics: Ambroxol; Humans; Lung Diseases, Obstructive; Smoking | 1997 |
Preventing exacerbations of chronic bronchitis and COPD.
Topics: Acetylcysteine; Adjuvants, Immunologic; Ambroxol; Antioxidants; Bacteria; Bronchitis; Cell Extracts; | 2001 |
[Therapeutic study on ambroxol in chronic bronchopulmonary diseases (author's transl)].
Topics: Ambroxol; Bromhexine; Bronchitis; Chronic Disease; Cryptococcosis; Humans; Lung Diseases; Lung Disea | 1978 |
[Prophylaxis and treatment of bronchopulmonary complications with ambroxol administered by infusion in elderly patients undergoing surgery].
Topics: Adult; Aged; Aged, 80 and over; Ambroxol; Bromhexine; Drug Evaluation; Female; Humans; Infusions, In | 1989 |
[Peroral therapy with expectorants].
Topics: Administration, Oral; Ambroxol; Bromhexine; Ciliary Motility Disorders; Expectorants; Humans; Lung D | 1988 |
Therapeutic activity of ambroxol theophyllinacetate in chronic obstructive pulmonary diseases.
Topics: Aged; Ambroxol; Bromhexine; Drug Evaluation; Female; Humans; Lung Diseases, Obstructive; Male; Theop | 1985 |